Organoids in modelling infectious diseases

Drug Discov Today. 2022 Jan;27(1):223-233. doi: 10.1016/j.drudis.2021.08.005. Epub 2021 Aug 18.

Abstract

Approaches based on animal and two-dimensional (2D) cell culture models cannot ensure reliable results in modeling novel pathogens or in drug testing in the short term; therefore, there is rising interest in platforms such as organoids. To develop a toolbox that can be used successfully to overcome current issues in modeling various infections, it is essential to provide a framework of recent achievements in applying organoids. Organoids have been used to study viruses, bacteria, and protists that cause, for example, respiratory, gastrointestinal, and liver diseases. Their future as models of infection will be associated with improvements in system complexity, including abilities to model tissue structure, a dynamic microenvironment, and coinfection. Teaser. Organoids are a flexible tool for modelling viral, bacterial and protist infections. They can provide fast and reliable information on the biology of pathogens and in drug screening, and thus have become essential in combatting emerging infectious diseases.

Keywords: Bacteria; Drug screening; Infection; Infectious diseases; Organoids; Protists; Viruses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cells, Cultured
  • Drug Evaluation, Preclinical* / methods
  • Drug Evaluation, Preclinical* / trends
  • Infections* / drug therapy
  • Infections* / microbiology
  • Models, Animal
  • Organoids* / drug effects
  • Organoids* / microbiology
  • Reproducibility of Results